Artwork

A tartalmat a Patti Mulligan biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Patti Mulligan vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
Player FM - Podcast alkalmazás
Lépjen offline állapotba az Player FM alkalmazással!

S7E9 - Zack Brown – Benefit-cost analysis and alternatives for evaluating biotechnology policy

59:49
 
Megosztás
 

Manage episode 359522275 series 2982476
A tartalmat a Patti Mulligan biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Patti Mulligan vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

Benefit-cost analysis and alternatives for evaluating biotechnology policy

Zachary S. Brown, Associate Professor of Agricultural & Resource Economics, NC State

Website | Twitter @TheKazath A look at the limits of benefit-cost analysis (BCA) in biotechnology governance and discussion of its social utility compared to alternatives.

Abstract

Benefit-cost analysis (BCA) is a ubiquitous method for evaluating policies throughout the US federal and state governments and around the world. It has been used for both normative and descriptive purposes, both prospectively and retrospectively, to assess the economic efficiency of policies. However, there are significant and well-known limitations in the method, especially in its insensitivity to fairness, equity, and justice. With these considerations receiving increasing prominence in political and policy discourses, including those surrounding biotechnology governance, what is the social utility of BCA going forward (compared to alternatives)? In this colloquium, I will quickly review the basic economic theory motivating BCA, summarizing some of my recent research deconstructing the method’s inherent indeterminism. I will then outline different areas of biotechnology policy in the US government where a role for BCA has been – or could be – implicated. I will describe a partial BCA from my own research evaluating the consumer welfare implications of agricultural gene drives, to motivate audience discussion questioning the utility of BCA in biotechnology governance.

Related links:

  • Brown, Z. S. (2022). Distributional policy impacts, WTP-WTA disparities, and the Kaldor-Hicks tests in benefit-cost analysis. Journal of Environmental Economics and Management, 113, 102654. https://doi.org/10.1016/j.jeem.2022.102654. PDF >
  • Jones, M. S., Delborne, J. A., Elsensohn, J., Mitchell, P. D., & Brown, Z. S. (2019). Does the US public support using gene drives in agriculture? And what do they want to know? Science Advances, 5(9), eaau8462. https://doi.org/10.1126/sciadv.aau8462. PDF >
  • Jones, M. S., & Brown, Z. S. (2019). Landscape-level pest control externalities when consumer preferences are non-neutral. In 2019 Annual Meeting, July 21-23, Atlanta, Georgia (No. 290815). Agricultural and Applied Economics Association. PDF >

Speaker Bio

Dr. Zack Brown is an Associate Professor in the Department of Agricultural and Resource Economics, serves on the Executive Committee of the Genetic Engineering and Society (GES) Center, and is also a faculty affiliate of the Center for Environmental and Natural Resource Economics and Policy (CEnREP) at NC State. He teaches classes in environmental and resource economics in NC State’s Economics Graduate Program and also teaches and advises students in the AgBioFEWS graduate fellowship program funded by the National Science Foundation. His research broadly examines questions in the field of bioeconomics, examining interactions between economic agents and biological and ecological systems.

GES Colloquium (GES 591-002) is jointly taught by Drs. Jen Baltzegar and Dawn Rodriguez-Ward, who you may contact with any class-specific questions. Colloquium will generally be live-streamed via Zoom, with monthly in-person meetings in 1911 Building Room 129. Please subscribe to the GES newsletter and Twitter for updates.

Genetic Engineering and Society Center

GES Colloquium - Tuesdays 12-1PM (via Zoom) NC State University | http://go.ncsu.edu/ges-colloquium GES Mediasite - See videos, full abstracts, speaker bios, and slides https://go.ncsu.edu/ges-mediasite Twitter - https://twitter.com/GESCenterNCSU

GES Center - Integrating scientific knowledge & diverse public values in shaping the futures of biotechnology.

Find out more at https://ges-center-lectures-ncsu.pinecast.co

  continue reading

137 epizódok

Artwork
iconMegosztás
 
Manage episode 359522275 series 2982476
A tartalmat a Patti Mulligan biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Patti Mulligan vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

Benefit-cost analysis and alternatives for evaluating biotechnology policy

Zachary S. Brown, Associate Professor of Agricultural & Resource Economics, NC State

Website | Twitter @TheKazath A look at the limits of benefit-cost analysis (BCA) in biotechnology governance and discussion of its social utility compared to alternatives.

Abstract

Benefit-cost analysis (BCA) is a ubiquitous method for evaluating policies throughout the US federal and state governments and around the world. It has been used for both normative and descriptive purposes, both prospectively and retrospectively, to assess the economic efficiency of policies. However, there are significant and well-known limitations in the method, especially in its insensitivity to fairness, equity, and justice. With these considerations receiving increasing prominence in political and policy discourses, including those surrounding biotechnology governance, what is the social utility of BCA going forward (compared to alternatives)? In this colloquium, I will quickly review the basic economic theory motivating BCA, summarizing some of my recent research deconstructing the method’s inherent indeterminism. I will then outline different areas of biotechnology policy in the US government where a role for BCA has been – or could be – implicated. I will describe a partial BCA from my own research evaluating the consumer welfare implications of agricultural gene drives, to motivate audience discussion questioning the utility of BCA in biotechnology governance.

Related links:

  • Brown, Z. S. (2022). Distributional policy impacts, WTP-WTA disparities, and the Kaldor-Hicks tests in benefit-cost analysis. Journal of Environmental Economics and Management, 113, 102654. https://doi.org/10.1016/j.jeem.2022.102654. PDF >
  • Jones, M. S., Delborne, J. A., Elsensohn, J., Mitchell, P. D., & Brown, Z. S. (2019). Does the US public support using gene drives in agriculture? And what do they want to know? Science Advances, 5(9), eaau8462. https://doi.org/10.1126/sciadv.aau8462. PDF >
  • Jones, M. S., & Brown, Z. S. (2019). Landscape-level pest control externalities when consumer preferences are non-neutral. In 2019 Annual Meeting, July 21-23, Atlanta, Georgia (No. 290815). Agricultural and Applied Economics Association. PDF >

Speaker Bio

Dr. Zack Brown is an Associate Professor in the Department of Agricultural and Resource Economics, serves on the Executive Committee of the Genetic Engineering and Society (GES) Center, and is also a faculty affiliate of the Center for Environmental and Natural Resource Economics and Policy (CEnREP) at NC State. He teaches classes in environmental and resource economics in NC State’s Economics Graduate Program and also teaches and advises students in the AgBioFEWS graduate fellowship program funded by the National Science Foundation. His research broadly examines questions in the field of bioeconomics, examining interactions between economic agents and biological and ecological systems.

GES Colloquium (GES 591-002) is jointly taught by Drs. Jen Baltzegar and Dawn Rodriguez-Ward, who you may contact with any class-specific questions. Colloquium will generally be live-streamed via Zoom, with monthly in-person meetings in 1911 Building Room 129. Please subscribe to the GES newsletter and Twitter for updates.

Genetic Engineering and Society Center

GES Colloquium - Tuesdays 12-1PM (via Zoom) NC State University | http://go.ncsu.edu/ges-colloquium GES Mediasite - See videos, full abstracts, speaker bios, and slides https://go.ncsu.edu/ges-mediasite Twitter - https://twitter.com/GESCenterNCSU

GES Center - Integrating scientific knowledge & diverse public values in shaping the futures of biotechnology.

Find out more at https://ges-center-lectures-ncsu.pinecast.co

  continue reading

137 epizódok

All episodes

×
 
Loading …

Üdvözlünk a Player FM-nél!

A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.

 

Gyors referencia kézikönyv

Hallgassa ezt a műsort, miközben felfedezi
Lejátszás